| NCT ID | NCT04110613 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Carilion Clinic |
| Condition | Critical Illness |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,200 participants |
| Start Date | 2019-09-19 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,200 participants in total. It began in 2019-09-19 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Randomized controlled trial to establish evidence on which to base timing of enteral feeding after bedside PEG placement in ventilated Trauma and Surgical ICU patients.
Eligibility Criteria
Inclusion Criteria: * Adult subjects over 18 years of age * Negative pregnancy test for women participants of child-bearing age * Mechanically ventilated surgical and trauma patients with clinical indication for PEG tube placement * Tolerating tube feeds at goal prior to procedure Exclusion Criteria: * Patients with aberant gastrointestinal anatomy * Patients with gastrointestinal motility disorders * Patients with feeding intolerance prior to PEG tube procedure * Pregnant women, children, or other vulnerable populations * Clinical contraindications for PEG tube placement * PEG performed in setting other than ICU at bedside
Contact & Investigator
Katie L Bower, MD
PRINCIPAL INVESTIGATOR
Carilion Clinic, Virginia Tech Carilion School of Medicine
Frequently Asked Questions
Who can join the NCT04110613 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Critical Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04110613 currently recruiting?
Yes, NCT04110613 is actively recruiting participants. Contact the research team at klbower@vt.edu for enrollment information.
Where is the NCT04110613 trial being conducted?
This trial is being conducted at Roanoke, United States.
Who is sponsoring the NCT04110613 clinical trial?
NCT04110613 is sponsored by Carilion Clinic. The principal investigator is Katie L Bower, MD at Carilion Clinic, Virginia Tech Carilion School of Medicine. The trial plans to enroll 1,200 participants.